ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDEN Eden Research Plc

4.45
0.00 (0.00%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.45 4.30 4.60 4.45 4.45 4.45 343,084 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.60 23.73M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.45p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 9.95p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.73 million. Eden Research has a price to earnings ratio (PE ratio) of -10.60.

Eden Research Share Discussion Threads

Showing 16301 to 16320 of 18300 messages
Chat Pages: Latest  660  659  658  657  656  655  654  653  652  651  650  649  Older
DateSubjectAuthorDiscuss
04/12/2023
16:04
Investingisatrickygame4 Dec '23 - 15:56 - 15906 of 15906
0 0 0
Brucie5
It seems to me you are making judgements today, based on the past, but the past is not where Eden is today. Review where we are today and make a judgement based on that. If we all based Eden on the past, we wouldn't be invested, would we!
------------------------------------------------------------------------------
Investing, call it a case of once; no, twice; no thrice bitten...
As stated I have taken out a starter position once again. My last bite was at 3p, when unfortunately my nerv3es caught a chill and I exited prematurely just before it rose to 12p in June; only to slump again.
I am giving them some benefit of the doubt on account of the cash runway and a certain amount of excitement over Ecovelex. Thus far, andn for time being, very little further, though of course, I am open to being pleasantly surprised should the proverbial leopard change its spots.

brucie5
04/12/2023
16:01
> Sales.

And so far, against years of promises, it's next to nothing.
….
I agree, sales for a number of years have been dire, no other word for it, but sales ‘21 to ‘22 were up 44.3% and are expected to be even higher ‘22 to ‘23 at> 55%.

During 2023 Mevalone and Cedroz approved in the largest single market, the USA with California state approval of Mevalone expected any day now. Ecovelex approvals in EUA coming soon along with launch of new product with the insecticide.

The tide has turned in my opinion.

kittybiscuits
04/12/2023
15:56
Brucie5

I think you're being too harsh. Eden didn't have the regulatory footprint years ago, or the label extension opportunities. That has and is changing right now.

They didn't have a global seed product back then; they do now and the recent online investor conference explained that when the current incumbent is soon removed, there is nothing to repel birds, save Ecovelex. This will deliver significant sales for Eden.

Furthermore, why would one company spend a not insignificant sum trialling 140 locations for Eden's soon to be announced and contracted, global insecticide. Because they clearly believe that insecticide might/will work for them globally.

It seems to me you are making judgements today, based on the past, but the past is not where Eden is today. Review where we are today and make a judgement based on that. If we all based Eden on the past, we wouldn't be invested, would we!

investingisatrickygame
04/12/2023
15:05
Love your enthusiasm, Kitty, but repeat after me: What's it all about?

Sales.

And so far, against years of promises, it's next to nothing.

brucie5
04/12/2023
14:55
+ The global biopesticides market is projected to be worth more than $11 billion by 2027

+ 30% of active ingredients in the EU are at medium to high risk of failing to receive renewal of their regulatory authorisations (Due to chemical bans/microplastics etc)

+ 15%....the biopesticides market is growing at compounded annual growth rate of 15%

Which company is now primed to take advantage of those numbers? I know!

kittybiscuits
04/12/2023
14:42
Opportunity.. bigger than Cedroz and Mevalone combined.
supersonico
04/12/2023
14:41
A global deal.
supersonico
04/12/2023
14:39
A Dearth of bio insecticide product available .. so much interest in the product.
supersonico
04/12/2023
14:06
Covert videos of Mock Auctions are available on Youtube.

Anyone who doesn't understand the SCAM that is conducted on this bulletin board should watch a few of them. The technique is the same, variations are minor.

This is also a BOILER ROOM. Operated by FILTH.

neutralpov
04/12/2023
12:44
Investing, you wouldn't expect me to argue against what you wrote!
attyg
04/12/2023
12:33
AttyG

Alex also states that Ecovelex sales should hit peak sales 'in short order'. So as you rightly point out in various posts, Eden should move to profit quickly, 2024 in my opinion and the rise from €2 million- €100 million per annum could come quite quickly for Eden, given where we are today and accepting that 3-5 years ago we were not in a position anywhere as near as positive as now.

investingisatrickygame
04/12/2023
07:32
At 13.10 on the 1 Dec Virtual Presentation Sean, talking of Californian approval for Mevalone says "... in the process of going through public consultation....and we expect that authoristation in very short order.."

Public consultation: Difficult to think that is interviewing people on the street or asking members of the public to write in and approve or reject mevalone. I am thinking it must be making enquiries within the industry? Just my guess. If so, then I was lead to believe that the farmers etc are desperate for mevalone. Again - just my understanding. However, that understanding chimes with Sean saying - in very short order.
I am sure Alex refers to Californian approval in similarly confident tones, later on this presentation.
I conclude Eden continues to expect approval soon - if within the next, what, two weeks, then we may be able to ship the Sipcam order before the y/e.
Just a thought.

attyg
03/12/2023
21:43
Investingisatrickygame3 Dec '23 - 17:34 - 15890 of 15892
0 0 1
Brucie5

The cash raise will last longer than a year. Where do you get one year from?
----------------------------------------------------------------------------
Think of a number; then halve it.
;)

brucie5
03/12/2023
19:41
The game dramatically changed in 2018 and those who think Eden are at the same point they were five years ago will shortly learn how very poorly they have informed themselves in the intervening years.
supersonico
03/12/2023
18:12
Brucie, please do not take my comments as investment advice.

Regarding capital destruction - I know all about that from having bought lots at much higher prices than 4p - though it can be said that a share price does not have much further to fall when it is at 4p. So, in my view, the downside is small and the upside is great.

DYOR

attyg
03/12/2023
17:34
Brucie5

The cash raise will last longer than a year. Where do you get one year from?

investingisatrickygame
03/12/2023
16:27
AttyG3 Dec '23 - 15:31 - 15886 of 15887
----------------------------------------
Good post, Atty; BUT you were saying similar about five years ago, as many were. Credibility of sales is now shot to pieces, so it matters little what projection sizes might suggest, if the material amounts continue to be miniscule. This needs to change.
That said - yes, obviously I can see the story and that has given the bod many years of stringing investor interest along. Whatever happened to the back to school flea treatment, lols?!
The fact that I now have a holding again is more to do with 1. the current discount to recent raise at 6.5p. 2. the fact that they did well to persuade another lot of investors to give them the necessary cash for another year. But it now needs to come good, so that the next raise, which there will quite inevitably be, will be at appreciably higher price.
I don't mean to sound snide about you or other enthusiasts here - it's great that you're so positive and many of us learn from your research. But this share is - and always has been - very high risk for capital destruction.

brucie5
03/12/2023
16:15
“How quickly can Eden grow from £2m sales to £100m sales?
Answer: They can do that in one year.
When are they going to do that then?
Answer: When they receive regulatory approval.“

Yes, this has been the sales pitch for the last 25 years

The problem is that the regulatory approval always seems to need further approval, either not previously mentioned by the board, or else seeming to come as a complete surprise to them

The EU regulatory approval received in 2014 does not seem to have moved matters forward one iota, despite all the trumpeting at the time

gemstar2
03/12/2023
15:34
Ha ha. Brilliant super - we're gonna need more dreams to spend all our money!
attyg
03/12/2023
14:05
WARNING TO ANY POTENTIAL INVESTORS STRAYING INTO THIS THREAD.

This thread is a BOILER ROOM SCAM.

This "Research" (lol) share, note NOT a "Sales" share, is relentlessly ramped by a small gang of multi-avatar liars, PAID or desperate holders looking to engineer a way out.

The only significant institutional is trying to get out too.

THIS IS ONLY FOR THOSE WHO LIKE MAKING CHARITABLE CONTRIBUTIONS TO GREEDY A'WIPES....

neutralpov
Chat Pages: Latest  660  659  658  657  656  655  654  653  652  651  650  649  Older

Your Recent History

Delayed Upgrade Clock